Adjuvant Quisinostat in High-Risk Uveal Melanoma

NCT06932757 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Uveal Melanoma

Interventions

DRUG: Quisinostat

Sponsor

University of Miami

Collaborators

[object Object]
[object Object]